Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTYP01 in Acute Ischemic Stroke
NCT06648304Phase 3Completed
- Start
- Apr 2023
- Primary completion
- Jun 2024
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of FAB122 in ischemic stroke. Started Apr 2023; status: completed.
02
Drugs
FAB122
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06648304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648304.